The current model of TwoF is that of a "foundry". Its subsidiary, Molecular Stamping, designs, manufactures and is starting to sell custom microarrays with user-specified content.
This strategy is based on two assumptions:
- The core advantage of the company is to provide microarrays that can compete on reliability, versatility, and cost. SuNS technology is flexible, both cost-effective and enormously versatile with regard to probe density and surface type.
- Off-the-shelf microarrays with standard content (such as those employed in genotyping and gene expression) are successfully supplied by other manufacturers. However, there is still growing and unmet demand for custom applications. This market is highly dynamic and a new entrant may be hampered by limiting themselves to supplying a catalogue of pre-established content on a rigid form-factor. SuNS microarrays have the potential to be read by almost any analytical platform, harvesting new demand from existing and new users who were previously deterred by high prices or lack of customization.
In the past two years, Molecular Stamping established partnerships with users in the R&D community to develop custom arrays that meet specific research requirements. Development partners have been identified in applications such as Environmental Monitoring, Human Genetics, and Human Diagnostics. Molecular Stamping is also actively exploring the clinical market.